[144] Clearwater Analytics Holdings, Inc. SEC Filing
Form 144 filed for Clearwater Analytics Holdings, Inc. (CWAN) reports a proposed sale of 10,000 common shares through Morgan Stanley Smith Barney, valued at $207,700, with an approximate sale date of 09/08/2025 on the NYSE. The filing shows the shares were acquired as Restricted Stock Units on 02/28/2024 and paid on that date. It also discloses two recent sales by the same person: a 10,000‑share 10b5�1 sale on 08/20/2025 for $200,000 and a 5,273‑share sale on 06/30/2025 for $114,282.78. The filer affirms no undisclosed material adverse information and references Rule 10b5�1 where applicable.
Presentato il Modulo 144 per Clearwater Analytics Holdings, Inc. (CWAN) che segnala la proposta vendita di 10.000 azioni ordinarie tramite Morgan Stanley Smith Barney, valutate $207.700, con data di vendita prevista intorno al 08/09/2025 sulla NYSE. La comunicazione indica che le azioni sono state acquisite come Restricted Stock Units il 28/02/2024 e corrisposte in quella data. Vengono inoltre dichiarate due vendite recenti della stessa persona: una vendita 10b5�1 di 10.000 azioni il 20/08/2025 per $200.000 e una vendita di 5.273 azioni il 30/06/2025 per $114.282,78. Il dichiarante conferma l'assenza di informazioni negative materiali non divulgate e fa riferimento alla Rule 10b5�1 quando applicabile.
Se presentó el Formulario 144 para Clearwater Analytics Holdings, Inc. (CWAN), que informa una propuesta de venta de 10.000 acciones ordinarias a través de Morgan Stanley Smith Barney, valoradas en $207.700, con fecha aproximada de venta el 08/09/2025 en la NYSE. La presentación indica que las acciones se adquirieron como Restricted Stock Units el 28/02/2024 y se pagaron en esa fecha. También se revelan dos ventas recientes de la misma persona: una venta 10b5�1 de 10.000 acciones el 20/08/2025 por $200.000 y una venta de 5.273 acciones el 30/06/2025 por $114.282,78. El declarante afirma que no hay información adversa material no divulgada y hace referencia a la Regla 10b5�1 cuando procede.
Clearwater Analytics Holdings, Inc.(CWAN)� 대� Form 144 제출은 Morgan Stanley Smith Barney� 통해 10,000 보통주를 매각하려� 제안� 보고하고 있으�, 평가금액은 $207,700, 매각 예정일은 � 2025� 9� 8�� NYSE에서 이루어질 예정입니�. 제출서에� 해당 주식� Restricted Stock Units� 2024� 2� 28�� 취득되어 같은 � 지급되었음� 기재되어 있습니다. 또한 동일 인물� 최근 � 건의 매각� 공개되어 있는�, 2025� 8� 20�� 10b5�1� 따른 10,000� 매각(금액 $200,000)� 2025� 6� 30�� 5,273� 매각(금액 $114,282.78)입니�. 신고자는 공개되지 않은 중대� 불리� 정보가 없음� 확인하며, 해당되는 경우 Rule 10b5�1� 언급합니�.
Formulaire 144 déposé pour Clearwater Analytics Holdings, Inc. (CWAN) signale une proposition de vente de 10 000 actions ordinaires via Morgan Stanley Smith Barney, évaluées à 207 700 $, avec une date de vente approximative le 08/09/2025 sur le NYSE. Le dépôt indique que les actions ont été acquises en tant que Restricted Stock Units le 28/02/2024 et payées à cette date. Il divulgue également deux ventes récentes par la même personne : une vente 10b5�1 de 10 000 actions le 20/08/2025 pour 200 000 $ et une vente de 5 273 actions le 30/06/2025 pour 114 282,78 $. Le déclarant affirme qu'il n'existe pas d'informations défavorables matérielles non divulguées et se réfère, le cas échéant, à la règle 10b5�1.
Formular 144 eingereicht ü Clearwater Analytics Holdings, Inc. (CWAN) meldet einen geplanten Verkauf von 10.000 Stammaktien über Morgan Stanley Smith Barney im Wert von $207.700, mit einem ungefähren Verkaufstermin am 08.09.2025 an der NYSE. Die Einreichung weist aus, dass die Aktien am 28.02.2024 als Restricted Stock Units erworben und an diesem Datum ausgezahlt wurden. Außerdem werden zwei jüngste Verkäufe derselben Person offengelegt: ein 10b5�1‑Verkauf von 10.000 Aktien am 20.08.2025 ü $200.000 und ein Verkauf von 5.273 Aktien am 30.06.2025 ü $114.282,78. Der Einreicher bestätigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen, und verweist gegebenenfalls auf Regel 10b5�1.
- Disclosure compliance: The filer provides broker, acquisition method, dates, and values, meeting Rule 144 reporting requirements
- Use of 10b5�1: Prior 10b5�1 sale is documented, indicating pre‑planned trading activity
- Insider sale disclosed: Proposed sale of 10,000 shares and recent sales (10,000 and 5,273 shares) may be viewed unfavorably by some investors despite being immaterial in size
Insights
TL;DR: Insiders disclosed routine sales totaling small fractions of outstanding shares; this is compliance reporting rather than a material corporate event.
The filing documents a proposed sale of 10,000 common shares valued at $207,700 and notes two recent disposals in June and August 2025. Compared with the issuer's reported outstanding shares (287,938,740), these transactions represent an immaterial ownership change by percentage terms. The sale origin—RSUs granted 02/28/2024—suggests this is disciplined monetization of equity awards rather than a financing or change in control. Investors should view this as standard insider liquidity activity disclosed under Rule 144 and 10b5�1 procedures.
TL;DR: The form reflects standard insider compliance with Rule 144/10b5�1; timing and prior 10b5�1 sale are documented and appropriate.
The notice identifies the broker, planned sale date, acquisition via RSUs, and prior 10b5�1 sales, which aligns with good disclosure practice. The filer certifies absence of undisclosed material adverse information and notes plan adoption/instruction fields, preserving the safe harbor. Given the quantities and the RSU origin, this filing signals routine governance and insider liquidity rather than governance red flags. Materiality to shareholders is limited based on absolute and relative sizes disclosed.
Presentato il Modulo 144 per Clearwater Analytics Holdings, Inc. (CWAN) che segnala la proposta vendita di 10.000 azioni ordinarie tramite Morgan Stanley Smith Barney, valutate $207.700, con data di vendita prevista intorno al 08/09/2025 sulla NYSE. La comunicazione indica che le azioni sono state acquisite come Restricted Stock Units il 28/02/2024 e corrisposte in quella data. Vengono inoltre dichiarate due vendite recenti della stessa persona: una vendita 10b5�1 di 10.000 azioni il 20/08/2025 per $200.000 e una vendita di 5.273 azioni il 30/06/2025 per $114.282,78. Il dichiarante conferma l'assenza di informazioni negative materiali non divulgate e fa riferimento alla Rule 10b5�1 quando applicabile.
Se presentó el Formulario 144 para Clearwater Analytics Holdings, Inc. (CWAN), que informa una propuesta de venta de 10.000 acciones ordinarias a través de Morgan Stanley Smith Barney, valoradas en $207.700, con fecha aproximada de venta el 08/09/2025 en la NYSE. La presentación indica que las acciones se adquirieron como Restricted Stock Units el 28/02/2024 y se pagaron en esa fecha. También se revelan dos ventas recientes de la misma persona: una venta 10b5�1 de 10.000 acciones el 20/08/2025 por $200.000 y una venta de 5.273 acciones el 30/06/2025 por $114.282,78. El declarante afirma que no hay información adversa material no divulgada y hace referencia a la Regla 10b5�1 cuando procede.
Clearwater Analytics Holdings, Inc.(CWAN)� 대� Form 144 제출은 Morgan Stanley Smith Barney� 통해 10,000 보통주를 매각하려� 제안� 보고하고 있으�, 평가금액은 $207,700, 매각 예정일은 � 2025� 9� 8�� NYSE에서 이루어질 예정입니�. 제출서에� 해당 주식� Restricted Stock Units� 2024� 2� 28�� 취득되어 같은 � 지급되었음� 기재되어 있습니다. 또한 동일 인물� 최근 � 건의 매각� 공개되어 있는�, 2025� 8� 20�� 10b5�1� 따른 10,000� 매각(금액 $200,000)� 2025� 6� 30�� 5,273� 매각(금액 $114,282.78)입니�. 신고자는 공개되지 않은 중대� 불리� 정보가 없음� 확인하며, 해당되는 경우 Rule 10b5�1� 언급합니�.
Formulaire 144 déposé pour Clearwater Analytics Holdings, Inc. (CWAN) signale une proposition de vente de 10 000 actions ordinaires via Morgan Stanley Smith Barney, évaluées à 207 700 $, avec une date de vente approximative le 08/09/2025 sur le NYSE. Le dépôt indique que les actions ont été acquises en tant que Restricted Stock Units le 28/02/2024 et payées à cette date. Il divulgue également deux ventes récentes par la même personne : une vente 10b5�1 de 10 000 actions le 20/08/2025 pour 200 000 $ et une vente de 5 273 actions le 30/06/2025 pour 114 282,78 $. Le déclarant affirme qu'il n'existe pas d'informations défavorables matérielles non divulguées et se réfère, le cas échéant, à la règle 10b5�1.
Formular 144 eingereicht ü Clearwater Analytics Holdings, Inc. (CWAN) meldet einen geplanten Verkauf von 10.000 Stammaktien über Morgan Stanley Smith Barney im Wert von $207.700, mit einem ungefähren Verkaufstermin am 08.09.2025 an der NYSE. Die Einreichung weist aus, dass die Aktien am 28.02.2024 als Restricted Stock Units erworben und an diesem Datum ausgezahlt wurden. Außerdem werden zwei jüngste Verkäufe derselben Person offengelegt: ein 10b5�1‑Verkauf von 10.000 Aktien am 20.08.2025 ü $200.000 und ein Verkauf von 5.273 Aktien am 30.06.2025 ü $114.282,78. Der Einreicher bestätigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen, und verweist gegebenenfalls auf Regel 10b5�1.